Together this data indicates that we have designed highly efficient sgRNAs that are able to efficiently and specifically target the MIEN1 gene and that knocking out MIEN1 does not affect the morphology, growth and survival of breast cancer cells. Here, MIEN1 is linked to breast carcinoma.